Диссертация (1174269), страница 21
Текст из файла (страница 21)
Liu, H.Shan, J. Huang, N. Li, C. Hou, J. Pu // Europace – 2016 – Vol.18, № 4 – P.617–622.40.Wang, C. A Wide and Specific Spectrum of Genetic Variants andGenotype-Phenotype Correlations Revealed by Next-Generation Sequencing in Patientswith Left Ventricular Noncompaction / C. Wang, Y. Hata, K.Hirono, A. Takasaki, S.W.
Ozawa // Journal of the American Heart Association – 2016 – Vol.6, № 9.41.Abbasi, Y. The pathogenicity of genetic variants previously associated withleft ventricular non-compaction / Y. Abbasi, J. Jabbari, R.Jabbari, R.‐Q. Yang, B.Risgaard et al. // Molecular Genetics & Genomic Medicine – 2016 – Vol.4, № 2 –P.135–142.42.Fedida, J. Contribution of exome sequencing for genetic diagnostic inarrhythmogenic right ventricular cardiomyopathy/dysplasia / J. Fedida, V.
Fressart, P.Charron, E. Surget, T. Hery et al. // PLOS ONE – 2017 – Vol.12, № 8, – P. e0181840.43.Campbell, M. J. Exon 3 deletion of ryanodine receptor causes leftventricular noncompaction, worsening catecholaminergic polymorphic ventriculartachycardia, and sudden cardiac arrest / M. J. Campbell, R. J.
Czosek, R. B. Hinton, E.M. Miller // American Journal of Medical Genetics Part A – 2015 – Vol. 167, № 9 – P.2197–2200.44.Ohno, S. Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor isassociated with left ventricular non-compaction / S. Ohno, M. Omura, M. Kawamura,H. Kimura, H. Itoh et al. // Europace – 2015 – Vol. 16, № 11 – P. 1646–1654.45.Bhuiyan, Z. A. Expanding spectrum of human RYR2-related disease: newelectrocardiographic, structural, and genetic features / Z.
A. Bhuiyan, M. P. van den140Berg, J. Peter van Tintelen, M. T.E. Bink-Boelkens, A. C.P. Wiesfeld // Circulation –2007 – Vol. 116, № 14 – P.1569–1576.46.Sinagra, G. Genetic Cardiomyopathies / G. Sinagra, L. Mestroni, F.Camerini – Milano: Springer Milan, 2013.47.Walsh, R. Reassessment of Mendelian gene pathogenicity using 7,855cardiomyopathy cases and 60,706 reference samples / R. Walsh, K. L. Thomson, J. S.Ware, B.
H. Funke, J. Woodley et al. // Genetics in Medicine – 2007 – Vol. 19, № 2 –P.192–203.48.Благова, O. В. Миокардит как закономерный феномен у больных спервичным некомпактным миокардом: диагностика, лечение и влияние наисходы. / O. В. Благова, E.В.
Павленко, Н.В. Вариончик, A.В. Недоступ, В.П.Седов и др. // Российский кардиологический журнал – 2018 – № 2 – P. 44–52.49.Yancy, C. W. 2013 ACCF/AHA Guideline for the Management of HeartFailure: A Report of the American College of Cardiology Foundation/American HeartAssociation Task Force on Practice Guidelines / C. W. Yancy, M. Jessup, B.
Bozkurt ,J. Butler , D. E. Casey Jr. et al. // Circulation – 2013 – Vol.128, № 16.50.Kirk, R. The International Society for Heart and Lung TransplantationGuidelines for the management of pediatric heart failure: Executive summary / R. Kirk,A. I. Dipchand, D. N.
Rosenthal, L. Addonizio, M. Burch et al. // The Journal of Heartand Lung Transplantation – 2014 – Vol.33, № 9 – P.888–909.51.Stöllberger, C. CHADS2- and CHA2DS2VASc scores and embolic risk inleft ventricular hypertrabeculation/noncompaction / C.
Stöllberger, C. Wegner, J.Finsterer // Journal of Stroke and Cerebrovascular Diseases – 2013 – Vol.22, № 6 –P.709–712.52.Stöllberger, C. A Probable Life-Saving Switch from Apixaban toPhenprocoumon / C. Stöllberger, J. Finsterer // The Heart Surgery Forum – 2015 –Vol.18, № 5 – P.E186-187.14153.Goud, A. A rare form of cardiomyopathy: left ventricular non-compactioncardiomyopathy / A. Goud, S. Padmanabhan // Journal of Community Hospital InternalMedicine Perspectives – 2016 – Vol. 6, №1 – P.29888.54.Weiford, B. C.
Noncompaction of the ventricular myocardium / B. C.Weiford, V. D. Subbarao, K. M. Mulhern // Circulation – 2004 – Vol. 109, № 24 – P.2965–2971.55.Priori, S. G. 2015 ESC Guidelines for the management of patients withventricular arrhythmias and the prevention of sudden cardiac death: The Task Force forthe Management of Patients with Ventricular Arrhythmias and the Prevention of SuddenCardiac Death of the European Society of Cardiology (ESC). Endorsed by: Associationfor European Paediatric and Congenital Cardiology (AEPC) / S. G Priori, C.Blomström-Lundqvist, A. Mazzanti, N. Blom, M. Borggrefe et al.
// European HeartJournal, Volume – 2015 – Vol.36, №41 – P. 2793–2867.56.Alper, A. T. Catheter ablation of ventricular arrhythmia originating in thetricuspid annulus in a patient with biventricular noncompaction: a case report / A. T.Alper, B. Güngör, A. İ. Tekkeşin, C. Türkkan // Archives of the Turkish Society ofCardiology – 2015 – Vol.43, № 6 – P. 568–571.57.Kumar, N. Left Ventricular Assist Device Insertion in a Patient WithBiventricular Noncompaction Cardiomyopathy, Ebstein Anomaly, and a Left AtrialMass: A Case Report / N.
Kumar, C. A. Troianos, J. S. Baisden // A&A Case Reports, –2016 – Vol.7, №12 – P. 251–255.58.Kornberger, A. Left ventricular non-compaction cardiomyopathy and leftventricular assist device: a word of caution / A. Kornberger, U. A. Stock, P. Risteski, A.Beiras Fernandez // Journal of Cardiothoracic Surgery – 2016 – Vol.11, № 1 – P.108.59.Al-Kindi, S. G. Heart transplant outcomes in patients with left ventricularnon-compaction cardiomyopathy / S.
G. Al-Kindi, C. El-Amm, M. Ginwalla, B. D.Hoit, S. J. Park, G. H. Oliveira // The Journal of Heart and Lung Transplantation –2015 – Vol.34, № 6 – P.761–765.14260.Gan, C. Surgical restoration of left ventricular diastolic function: possibletreatment for noncompaction cardiomyopathy / C. Gan, J. Hu, S. Luo, Q. An, K. Lin //Journal of Cardiac Surgery – 2014 – Vol.29, № 6 – P. 827–828.61.Grothoff, M.
Value of cardiovascular MR in diagnosing left ventricularnon-compaction cardiomyopathy and in discriminating between other cardiomyopathies/ M. Grothoff, M. Pachowsky, J. Hoffmann, M. Posch, S. Klaassen et al. // EuropeanRadiology – 2012 – Vol. 22, № 12 – P. 2699–270962.Elliott, P.M. 2014 ESC Guidelines on diagnosis and management ofhypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management ofHypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) / P. M.Elliott, A.
Anastasakis, M. A. Borger, M. Borggrefe, F. Cecchi et al. // European HeartJournal – 2014 – Vol. 35, № 39 – P. 2733–2779.63.Wilkenshoff, U. Spravočnik po ėchokardiografii 82 tablicy / U.Wilkenshoff, I. Kruck // 2014.64.Mathew, T. Diagnosis and assessment of dilated cardiomyopathy: aguideline protocol from the British Society of Echocardiography / T. Mathew, L.Williams, G. Navaratnam, B. Rana, R. Wheeler et al. // Echo Research and Practice –2017 – Vol.4, № 2 – P.G1–G13.65.Sambrook, J.
Isolation of High-molecular-weight DNA from MammalianCells Using Proteinase K and Phenol J. Sambrook, D. W. Russell // Cold Spring HarborProtocols – 2017 – Vol. 2006, № 1.66.Hershberger, R. E. Genetic Evaluation of Cardiomyopathy-A Heart FailureSociety of America Practice Guideline / R. E. Hershberger, M.
M. Givertz, C. Y. Ho, D.P. Judge, P. F. Kantor et al. // Journal of Cardiac Failure – 2018 – Vol. 24, № 5 – P.281–302.67.Chang B., Identification of a novel TPM1 mutation in a family with leftventricular noncompaction and sudden death / B. Chang, T.
Nishizawa, M. Furutani, A.143Fujiki, M. Tani et al. // Molecular Genetics and Metabolism – 2011 – Vol. 102, № 2 –P. 200–206.68.van den Wijngaard, A. Recurrent and founder mutations in theNetherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms ofhypertrophic and restrictive cardiomyopathy / A. van den Wijngaard, P. Volders, J. P.Van Tintelen, J. D. H.
Jongbloed, M. P. van den Berg et al. // Netherlands HeartJournal – 2011 – Vol. 19, № 7–8 – P.344–351.69.Huang, W. Novel familial dilated cardiomyopathy mutation in MYL2affects the structure and function of myosin regulatory light chain / W. Huang, J. Liang,C.-C. Yuan, K. Kazmierczak, Z. Zhou et al. // FEBS Journal – 2015 – Vol. 282, № 12 –P.2379–2393.70.Dellefave, L. Sarcomere Mutations in Cardiomyopathy, Noncompaction,and the Developing Heart / L. Dellefave, E. M. McNally // Circulation – 2008 – Vol.117, № 22 – P.
2847–2849.71.Hermida-Prieto, M. Familial dilated cardiomyopathy and isolated leftventricular noncompaction associated with lamin A/C gene mutations / M. HermidaPrieto, L. Monserrat, A. Castro-Beiras, R. Laredo, R. Soler // The American Journal ofCardiology – 2004 – Vol.94, № 1 – P. 50–54.72.Olivotto, I. Gender-Related Differences in the Clinical Presentation andOutcome of Hypertrophic Cardiomyopathy / I. Olivotto, M. S. Maron, A. S. Adabag, S.A. Casey, D.
Vargiu et al. // Journal of the American College of Cardiology – 2005 –Vol.46, № 3 – P. 480–487.73.Terauchi, Y. Gender differences in the clinical features of hypertrophiccardiomyopathy caused by cardiac myosin-binding protein C gene mutations / Y.Terauchi, T. Kubo, Y. Baba, T.
Hirota, K. Tanioka et al. // Journal of Cardiology –2015 – Vol.65, № 5 – P. 423–428.74.Рыжкова, О. П. «Руководство по интерпретации данных, полученныхметодами массового параллельного секвенирования (MPS) / О. П. Рыжкова, О. Л.144Кардымон, Е. Б. Прохорчук, Ф. А. Коновалов, А. Б. Масленников и др. //Медицинская генетика – 2017 – Vol. 16, №7 – P.
4–17.75.Nykamp, K. Sherloc: a comprehensive refinement of the ACMG–AMPvariant classification criteria / K. Nykamp, M. Anderson, M. Powers, J. Garcia, B.Herrera et al. // Genetics in Medicine – 2017 – Vol. 19, №10 – P. 1105–1117.76.Harrison, S. M. Clinical laboratories collaborate to resolve differences invariant interpretations submitted to ClinVar / S.
M. Harrison, J. S. Dolinsky, A. E.Knight Johnson, T. Pesaran, D. R. Azzariti et al. // Genetics in Medicine – 2017 – Vol.19, №10 – P. 1096–1104.77.Whiffin, N. CardioClassifier: disease- and gene-specific computationaldecision support for clinical genome interpretation / N. Whiffin, R. Walsh, R. Govind,M. Edwards, M. Ahmad et al. // Genetics in Medicine – 2018 – Vol. 20, №10 – P.1246–1254.78.Li, S.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
